Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Oza, AM, Cook, AD, Pfisterer, J et al. (21 more authors) (2015) Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncology, 16 (8). pp. 928-936. ISSN 1470-2045

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Oza et al. Open Access article distributed under the terms of CC BY http://creativecommons.org/licenses/by/3.0/
Dates:
  • Accepted: 1 May 2015
  • Published (online): 23 June 2015
  • Published: August 2015
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 03 Mar 2016 14:23
Last Modified: 11 Apr 2018 15:51
Published Version: http://dx.doi.org/10.1016/S1470-2045(15)00086-8
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/S1470-2045(15)00086-8
Related URLs:

Export

Statistics